Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
106M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
26.9M
-
Shares change
-
-21.2K
-
Total reported value, excl. options
-
$290M
-
Value change
-
-$4.74M
-
Number of buys
-
42
-
Number of sells
-
-22
-
Price
-
$10.77
Significant Holders of Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) as of Q4 2018
75 filings reported holding RCUS - Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2018.
Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.9M shares
of 106M outstanding shares and own 25.47% of the company stock.
Largest 10 shareholders include Alphabet Inc. (5.05M shares), WELLINGTON MANAGEMENT GROUP LLP (4.28M shares), Svennilson Peter (3.54M shares), BVF INC/IL (2.41M shares), Foresite Capital Management III, LLC (2.03M shares), BlackRock Inc. (1.72M shares), EcoR1 Capital, LLC (1.22M shares), Vanguard Group Inc (1.11M shares), Aisling Capital Management LP (537K shares), and STATE STREET CORP (510K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.